Prospective Study of the Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as a New imMUne Prognostic Biomarker in Breast Cancer Treated by NEOadjuvant Chemotherapy
Interventional
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
Overall survival
Overall survival is defined as the time from inclusion date to death from any cause, or to date of last follow-up, if death does not occur.
From date of inclusion up to the end of follow-up period : december 2014 (anticipated)
No
Sylvain LADOIRE, MD
Principal Investigator
Centre Georges Francois Leclerc
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
2011-1SLa-01
NCT01513408
May 2012
December 2014
Name | Location |
---|